Dr. Chon owns stock or stock options in Amgen.
Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: A secondary analysis of clinical trial data from children with Polyarticular-Course Juvenile Idiopathic Arthritis
Version of Record online: 30 NOV 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 60, Issue 12, pages 3776–3783, December 2009
How to Cite
Ringold, S., Chon, Y. and Singer, N. G. (2009), Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: A secondary analysis of clinical trial data from children with Polyarticular-Course Juvenile Idiopathic Arthritis. Arthritis & Rheumatism, 60: 3776–3783. doi: 10.1002/art.24983
- Issue online: 30 NOV 2009
- Version of Record online: 30 NOV 2009
- Manuscript Accepted: 18 AUG 2009
- Manuscript Received: 24 MAR 2009
- Immunex Corporation, a wholly owned subsidiary of Amgen, Inc.
- Wyeth Pharmaceuticals
- Mentored Scholar Program of the Center for Clinical and Translational Research, Seattle Children's Hospital, Seattle, Washington
- 15Enbrel (etanercept) prescribing information. Thousand Oaks (CA): Immunex Corporation; 2009.
- 16JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Current proposed revision of the JRA criteria. Arthritis Rheum 1977; 20 Suppl 2: 195–9.
- 17Safety and efficacy of tumor necrosis factor receptor p75 Fc fusion protein (TNFR:Fc; Enbrel™) in polyarticular course juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 1998; 41 Suppl: S130., , , , .
- 21The Disease Activity Score (DAS) with extended joint counts in rheumatoid arthritis: update and validation of the original DAS formula [abstract]. Arthritis Rheum 2007; 56 Suppl: S709., , , .
- 23Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 34–40., , , , , .
- 24Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission. Clin Exp Rheumatol 2006; 24 Suppl 43: S22–8., , .
- 29A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti–tumor necrosis factor α agents. Arthritis Rheum 2006; 54: 1602–7., , , , , , et al.